Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Sponsor: Novartis Pharmaceuticals
Summary
The purpose of this study is to describe routine clinical practice with lutetium (177Lu) vipivotide tetraxetan on Health related quality of life (HRQoL) at baseline, on treatment, and post progression.
Official title: Real-world Experience With Lutetium (177Lu) Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer, an Observational, Multicenter, Prospective Cohort Study
Key Details
Gender
MALE
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-09-04
Completion Date
2028-02-01
Last Updated
2025-12-30
Healthy Volunteers
No
Interventions
lutetium (177Lu) vipivotide tetraxetan
This is an observational study. There is no treatment allocation. The decision to initiate lutetium vipivotide tetraxetan will be based solely on clinical judgement.
Locations (35)
Novartis Investigative Site
Konstanz, Baden-Wurttemberg, Germany
Novartis Investigative Site
Stuttgart, Baden-Wurttemberg, Germany
Novartis Investigative Site
Munich, Bavaria, Germany
Novartis Investigative Site
Regensburg, Bavaria, Germany
Novartis Investigative Site
Würzburg, Bavaria, Germany
Novartis Investigative Site
Cottbus, Brandenburg, Germany
Novartis Investigative Site
Frankfurt (Oder), Brandenburg, Germany
Novartis Investigative Site
Ludwigshafen, Germany, Germany
Novartis Investigative Site
Marburg, Hesse, Germany
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site
Dresden, Saxony, Germany
Novartis Investigative Site
Leipzig, Saxony, Germany
Novartis Investigative Site
Halle, Saxony-Anhalt, Germany
Novartis Investigative Site
Jena, Thuringia, Germany
Novartis Investigative Site
Aachen, Germany
Novartis Investigative Site
Augsburg, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Berlin, Germany
Novartis Investigative Site
Bielefeld, Germany
Novartis Investigative Site
Bonn, Germany
Novartis Investigative Site
Chemnitz, Germany
Novartis Investigative Site
Dortmund, Germany
Novartis Investigative Site
Dortmund, Germany
Novartis Investigative Site
Erlangen, Germany
Novartis Investigative Site
Essen, Germany
Novartis Investigative Site
Fulda, Germany
Novartis Investigative Site
Herford, Germany
Novartis Investigative Site
Homburg, Germany
Novartis Investigative Site
Magdeburg, Germany
Novartis Investigative Site
Mainz, Germany
Novartis Investigative Site
Rostock, Germany
Novartis Investigative Site
Trier, Germany
Novartis Investigative Site
Tübingen, Germany
Novartis Investigative Site
Ulm, Germany